Add BrightSurf on Google Email

JCI Journals


Preventing the progression of HIV

A study by Mayo Clinic researchers found that a specific Vpr mutation is associated with long-term nonprogressive HIV infection, where infected individuals exhibit preserved immune function. The discovery suggests a potential therapeutic opportunity for Vpr inhibitors to reduce T cell death during HIV infection.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMay 15, 2003

JCI table of contents, May 15, 2003

Scientists have made significant discoveries in the treatment of sinus node dysfunction, lupus, and cardiac failure, while also uncovering new mechanisms for bacterial defense and asthma treatment. These findings hold promise for developing more effective therapies.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMay 15, 2003

Estrogen regulates key factor in wound healing

MIF is a crucial intermediary in uncontrolled inflammation and impaired wound healing. In estrogen-deficient mice, MIF expression increased, leading to excessive inflammation and delayed healing. Therapeutics that inhibit MIF may accelerate wound healing.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMay 1, 2003

JCI Table of Contents, May 1, 2003

Researchers have successfully used syngeneic hematopoietic stem cell transplantation to prevent autoimmune diabetes in mice, providing a promising new approach for treating genetic disorders. This breakthrough is made possible by the discovery of natural gene therapy mechanisms that can reverse mutations causing rare inherited diseases...

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMay 1, 2003

JCI Table of Contents, April 15, 2003

Researchers investigate targeting pericytes and endothelial cells with kinase inhibitors to treat cancer and autoimmune diseases. PDX1 levels also play a crucial role in islet survival and diabetes development, while Factor H's anti-inflammatory properties are explored for hemolytic uremic syndrome treatment.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateApr 15, 2003

Immune responses to peanuts are key in a growing allergic phenomenon

A study published in JCI Journals identified unique immunological factors produced by immune cells of peanut-allergic children compared to non-allergic individuals and those who outgrown their allergies. These findings suggest the development of allergic reactions depends on host immune response rather than inherent allergenic properties.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateApr 1, 2003

JCI Table of Contents, April 1, 2003

Inhibition of RAGE suppressed neointimal formation in mice upon arterial injury and decreased SMC proliferation, migration, and expression of ECM proteins. Local mucosal immunization leads to antigen-specific IgA production at distant mucosal sites through the interaction between CCR10 and its mucosal epithelial ligand MEC.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateApr 1, 2003

Stem cells: From bone marrow to pancreas

Researchers successfully transplanted bone marrow cells from a male donor mouse to a female recipient, where they developed into functional insulin-expressing cells. The findings suggest that bone marrow may be a viable source for ex vivo expansion and autologous transplantation of pancreatic beta-cell precursors.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMar 14, 2003

JCI Table of Contents, March 14, 2003

Research highlights the role of WNK kinases in regulating thiazide-sensitive Na-Cl cotransport, a key mechanism for maintaining electrolyte balance. Additionally, studies investigate the immunomodulatory effects of WNK kinases on pulmonary inflammation and diabetes, shedding light on potential therapeutic targets.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMar 14, 2003

JCI table of contents, March 3, 2003

Scientists have discovered a possible acceleration of type 1 diabetes in proinsulin 2-deficient non-obese diabetic mice, while promoting lymphangiogenesis as a potential treatment for lymphedema. Additionally, researchers found that CD44 is involved in the binding and uptake of Mycobacterium tuberculosis, suggesting its role in tubercu...

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMar 4, 2003

The elusive preeclampsia factor discovered?

Scientists found that elevated levels of sFlt1 protein mediate the progression to preeclampsia by reducing angiogenic factors. Reducing VEGF-A in kidney cells also caused similar kidney disease, suggesting a plausible scenario for preeclampsia

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMar 4, 2003

Keeping blood pressure in check

A study found that mice deficient in RGS2, a regulatory protein, exhibited persistent vessel constriction and strongly hypertensive effects. This suggests that abnormally prolonged GPCR signaling may contribute to the onset of hypertension.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateFeb 15, 2003

JCI Table of Contents, February 14, 2003

Researchers found that RGS2-deficient mice developed strongly hypertensive conditions and persistent vessel constriction due to prolonged GPCR signaling. Genetic defects affecting RGS2 function may also contribute to hypertension in humans, according to findings published in the Journal of Clinical Investigation.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateFeb 15, 2003

JCI Table of Contents, February 3, 2003

A study published in the Journal of Clinical Investigation found that HIV protease inhibitors directly promote atherosclerosis in mice. In humans, researchers propose a mechanism by which these drugs might contribute to heart disease, suggesting ways to disrupt it.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateFeb 4, 2003

HAART and heart disease

Researchers found that HIV protease inhibitors directly promote atherosclerosis in mice by inducing changes in macrophages. A commentary article proposes a mechanism and suggests ways to disrupt this process. The study has significant implications for the long-term use of these drugs in managing chronic HIV infection.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateFeb 4, 2003

Artemis: a little bit is not enough

Individuals with reduced functional Artemis protein are prone to mild immunodeficiency and increased risk of developing lymphomas. This finding suggests that mutations in Artemis or other DNA repair genes may be responsible for immune deficiency and/or lymphoma cases.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateFeb 4, 2003

JCI table of contents, January 15 2003

Researchers have made significant progress in understanding the effects of HIV protease inhibitors on atherosclerosis, as well as exploring novel gene therapies for epidermolysis bullosa. Additionally, studies on CXCR4/CXCL12 interaction reveal new insights into hematopoietic stem cell mobilization.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJan 16, 2003

Early diagnosis of childhood diabetes

Scientists at British Columbia's Children's Hospital reveal a method for directly measuring the level of self-destructive white blood cells in mouse blood, distinguishing those that go on to develop diabetes from those that do not. The technique may also be used to detect other autoimmune disorders.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJan 16, 2003

Nicotine - Worse than we thought?

Research reveals nicotine activates Akt survival pathway, undermining programmed cell death in lung cancer cells. This finding may lead to re-evaluation of quitting-aids' benefits.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJan 2, 2003

JCI Table of Contents, January 2, 2003

Researchers found that nicotine stimulates lung epithelial cells to activate a molecular pathway promoting cell growth and survival. This activation undermines the body's natural defense mechanism against cancer. The study suggests reconsidering the risk-benefit ratio of nicotine-based quitting aids.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJan 2, 2003

Increased bone mass in a calcitonin knockout mouse full of surprises

Researchers discovered that calcitonin knockout mice have greater bone mass and increased bone formation, suggesting a novel function for the calcitonin gene product. This finding has implications for preventing bone loss associated with estrogen deficiency, potentially leading to new treatments for post-menopausal osteoporosis.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateDec 17, 2002

JCI table of contents, December 15, 2002

Research reveals that mice without the calcitonin gene exhibit greater bone mass and formation, suggesting a novel function for this hormone. This discovery opens up new avenues for preventing bone loss associated with estrogen deficiency.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateDec 17, 2002

JCI Table of Contents, December 2, 2002

Researchers have discovered that angiopoietin-1 can restore faulty blood vessel architecture in mice by promoting sprouting, survival, and stability of new vessels. This study highlights the importance of pericytes in maintaining normal vessel stability and may lead to new treatments for diseases like diabetic retinopathy.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateDec 3, 2002

The growing Staphylococcus aureus arsenal

The study reveals the role of Map in promoting S. aureus persistence and survival in infected mice by interfering with T cell function. Researchers warn that the increasing prevalence of multidrug-resistant strains poses a significant threat to public health.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateNov 19, 2002

Targeting bone metastasis and hypercalcemia

Researchers have identified two compounds that inhibit PTHrP production, reducing metastatic bone breakdown and tumor burden. The findings suggest potential therapeutic benefits for treating both bone metastasis and hypercalcemia in breast cancer patients.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateNov 19, 2002

JCI Table of Contents, November 18, 2002

Researchers discover two compounds that inhibit parathyroid hormone-related protein production in human breast cancer cells, reducing metastatic bone breakdown and calcium levels. The findings suggest a novel therapeutic approach to treating bone metastasis and hypercalcemia in breast cancer patients.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateNov 19, 2002

Feeding your fat

Researchers have discovered that nerves from the sympathetic branch of the nervous system (PSNS) are connected to fatty tissue, influencing its growth and function. This finding may lead to a better understanding of obesity-related conditions such as type II diabetes and high blood pressure.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateNov 5, 2002

JCI table of contents, November 4, 2002

Researchers found that HIV-specific killer T cells in asymptomatic individuals can recognize and kill both laboratory strain and autologous virus-infected target cells. However, these cells in symptomatic patients with AIDS are no longer effective against their own mutated virus.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateNov 5, 2002

Dispersin' Escherichia coli all over the gut

A new study reveals dispersin, a protein on the surface of E. coli bacteria, helps promote its ability to survive and spread in the gut. Dispersin is now being explored as a potential vaccine candidate due to its strong immune response-provoking properties.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateNov 5, 2002

How HIV outmaneuvers the immune system

A study published in the Journal of Clinical Investigation found that HIV-specific killer T cells in AIDS patients are remnants of a once-effective response early after infection. The high number of these cells can no longer recognize mutated autologous virus, leading to disease progression.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateNov 5, 2002

Getting more mileage out of cord blood

Researchers have developed a method to culture and expand cord blood-derived stem cells, increasing their number by over 100-fold. The expanded cells showed improved potency in reconstituting the recipient's blood and immune cell systems.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateOct 22, 2002

JCI table of contents, October 21, 2002

Researchers uncover the role of parasympathetic innervation in fat distribution, revealing functional implications for obesity. Additionally, studies explore the molecular mechanisms behind long QT-3 syndrome, immunodeficiencies, and intestinal lymphocyte recruitment, shedding light on novel therapeutic targets.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateOct 22, 2002

Ouch! The receptors mediating acidic pain sensation

A study by Shinya Ugawa and colleagues found that acid sensing ion channels (ASICs) function as acid sensors within a specific pH range, while VR1 receptors are not involved. The ASICs inhibitor amiloride may be a useful analgesic for treating localized pain within this range.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateOct 22, 2002

JCI table of contents: October 1, 2002

Scientists study emesis in genetically engineered mice lacking specific PDE4 subtypes and infer that inhibition of PDE4D mediates nausea. The discovery could lead to the development of selective PDE4 inhibitors with anti-inflammatory effects, reducing side effects in humans.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateOct 2, 2002

Beyond copolymer 1

Researchers at JCI Journals have made significant strides in understanding the biological function and clinical relevance of copolymers. The study's findings hold promise for developing new treatments for various human diseases.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJun 12, 2002

A detour for stalled intracellular lipid traffic

A recent study published in the Journal of Clinical Investigation has identified a potential detour for stalled intracellular lipid traffic. This novel approach could lead to the development of new treatments for various diseases, including those related to lipid metabolism.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJun 12, 2002

Tumor vaccines via dendritic cells

Tumor vaccines via dendritic cells aim to enhance the immune response against cancer cells Researchers found that dendritic cells can stimulate the production of antibodies and T-cells specific to cancer antigens

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMay 29, 2002

NEMO submerged in virus-prone boys

Researchers investigate NEMO submersion in virus-prone boys to identify potential risks and benefits. The study aims to provide a deeper understanding of the relationship between viral exposure and physiological responses.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMay 29, 2002

Pattern recognition receptors on mast cells

Pattern recognition receptors on mast cells play a crucial role in triggering an immune response and modulating inflammation. This receptor activation leads to the release of histamine and other pro-inflammatory mediators, contributing to various diseases such as allergic reactions and asthma.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMay 15, 2002

A new role for a versatile stem cell

A recent study published in JCI Journals reveals that a versatile stem cell can be repurposed to enhance tissue repair and regeneration in various tissues. The researchers discovered that the stem cell can differentiate into multiple cell types to facilitate the healing process.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMay 15, 2002